StonvexLoading…
StonvexStonvexStonvexCore line items from NSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.18B | $12.12B | $12.16B | $12.74B |
Operating Income | $4.36B | $4.07B | $2.85B | $4.81B |
Net Income | $2.87B | $2.62B | $1.83B | $3.27B |
EPS (Diluted) | $12.75 | $11.57 | $8.02 | $13.88 |
Total Assets | $45.24B | $43.68B | $41.65B | $38.88B |
Total Liabilities | $29.69B | $29.38B | $28.87B | $26.15B |
Cash & Equivalents | $1.53B | $1.64B | $1.57B | $456.00M |
Free Cash Flow OCF − CapEx | $2.16B | $1.67B | $852.00M | $2.27B |
Shares Outstanding | 224.42M | 226.32M | 225.68M | 228.08M |